Expert Profile

Allan Coukell

Senior Director, Drugs and Medical Devices
The Pew Charitable Trusts

Allan Coukell is senior director of drugs and medical devices, overseeing Pew’s initiatives related to drug and medical device innovation and safety, medical conflicts of interest, the pharmaceutical supply chain, pharmacy compounding, antibiotics, prescription drug abuse, the Food and Drug Administration, and specialty drugs, and other efforts related to health costs and care delivery.

Before joining Pew, he practiced as a clinical pharmacist in oncology at the London (Ontario) Health Sciences Center and the Ontario Regional Cancer Center, served as a senior medical writer and editor with the medical journal publisher Adis International, and covered health and science as a reporter and producer for WBUR (NPR) in Boston and Radio New Zealand.

He is vice chair of the Medical Device Innovation Consortium and a board member of the Reagan-Udall Foundation for the FDA. He served as a consumer representative on the FDA’s Cardiovascular and Renal Drugs Advisory Committee.

Subscribe to this feed

News Room

July 9, 2012

Pew Applauds Enactment of User Fee Legislation, Urges Its Swift Implementation

A statement by Allan Coukell, director of medical programs at Pew Health Group, about the enactment of the Food and Drug Administration Safety and Innovation Act.

June 26, 2012

Pew's Allan Coukell Discusses FDA Reform Act of 2012

Allan Coukell, deputy director of the Medical Safety Portfolio of the Pew Health Group, talks about drug safety on C-SPAN.

June 21, 2012

Pew Applauds U.S. House Passage of FDA User Fee Legislation

The U.S. House of Representatives Wednesday passed the Food and Drug Administration Safety and Innovation Act (S. 3187), a bill to support the FDA’s drug and device reviews. “We commend the House for passing the bipartisan Food and Drug Administration Safety and Innovation Act," said Allan Coukell, director of medical programs at the Pew Health Group.

May 30, 2012

Pew Applauds Passage of Bipartisan User Fee Legislation by U.S. House of Representatives

The U.S. House of Representatives passed bipartisan legislation to ensure that the U.S. Food and Drug Administration (FDA) has the funds it needs to approve products that improve health and protect consumers from unnecessary risks.

May 25, 2012

Senate Bill Aims to Increase Drug Import Safety

Allan Coukell, Pew Health Group medical director, is quoted in an Associated Press article about Senate passage of FDA user fee legislation that also aims to improve the safety and quality of imported drugs.

April 23, 2012

FDA Alerts Doctors on Fakes

An article in The Wall Street Journal on counterfeit drugs quotes Allan Coukell, medical director at Pew Health Group, over concerns about doctors purchasing cheaper foreign drugs.

March 29, 2012

Testimony of Allan Coukell before the Senate Committee on Health, Education, Labor and Pensions

Allan Coukell, Director of Medical Programs testifies before the Senate Committee on Health, Education, Labor and Pensions on the importance of the user fee agreement legislation to patients and public health.

March 28, 2012

Editorial: Crack Down on Counterfeit Drugs

An editorial in the Minneapolis Star Tribune about counterfeit drugs quotes Allan Coukell, medical director at Pew Health Group, on the need for a strong, uniform national standards and systems to track authentic drugs.

March 8, 2012

Testimony of Allan Coukell and Sharon Ladin before the House Committee on Energy and Commerce, Subcommittee on Health

Allan Coukell, Director of Medical Programs, and Sharon Ladin, Director of the Antibiotics and Innovation Project, testify before the House Committee on Energy and Commerce, Subcommittee on Health on stimulating the development of new antibiotics urgently needed to fight serious and life-threatening bacterial infections

February 16, 2012

Fakes Infiltrate Injectable Drugs

A Wall Street Journal article about counterfeit US drugs quotes Allan Coukell, deputy director at the Pew Health Group.

February 15, 2012

Pew Urges Congress to Pass Medical Device User Fee Act and Improve Marketplace Monitoring

A statement from Allan Coukell, director of medical programs at the Pew Health Group, about a hearing on the reauthorization of the Medical Device User Fee Act (MDUFA).

January 17, 2012

U.S. to Force Drug Firms to Report Money Paid to Doctors

Allan J. Coukell, director of medical programs at Pew Health Group, is quoted in the New York Times on the Obama administration's decision to require drug companies to disclose the payments they make to doctors.

January 17, 2012

FDA Would Collect Millions in Fees to Speed Review of Traditional and Biotech Generic Drugs

The Associated Press quotes Allan Coukell, director of medical programs at Pew Health Group, on the benefits stemming from the Food and Drug Administration's proposal to charge drug manufacturers new application fees for reviewing traditional and generic biotech drugs.

October 11, 2011

Editorial: Feds Fumble on Law Aimed at Doctors

Allan Coukell, director of medical programs at Pew Health group, is quoted in a Minneapolis Star Tribune editorial about the consensus around the Physician Payments Sunshine Act and the need to continue with its implementation.

September 21, 2011

Safer Drug Supply Requires Update to Our Regulation

An opinion editorial in The Hill by Patricia Benson and Allan Coukell outlines the need for a contemporary regulatory system for prescription drugs that will match today’s marketplace.

September 9, 2011

Drug Firms Paid N.J. Doctors $12.4 million in 2010

Allan Coukell, director of medical programs at Pew Health Group, is quoted in Star-Ledger (NJ) article about problems associated with drug makers payments to physicians

August 30, 2011

Distribution System OK, but it can be Exploited

A letter to the editor by Allan Coukell, director of Medical Programs at Pew Health Group, highlights the complexity of the drug distribution system and opportunities to protect patients.  

August 30, 2011

Pharma Groups Pay $150m to US Doctors

A Financial Times analysis of payments to doctors by pharmaceutical companies in the United States quotes Allan Coukell, director of Medical Programs at Pew Health Group, on the need for transparency.

July 12, 2011

Pew Finds Serious Gaps in Oversight of U.S. Drug Safety

Pew study recommends legislative fixes to reduce risks of counterfeit, adulterated and substandard pharmaceuticals.

February 24, 2011

Heparin Contamination: Lawmakers Want Answers

Allan Coukell, director of medical safety for Pew Health Group, notes the difficulties inherent in inspecting foreign drug manufacuring facilities under current regulations.

February 24, 2011

House Investigates Heparin Crisis

The Pew Health Group's Allan Coukell is quoted in a Wall Street Journal article about a Congressional investigation into the contaminated-heparin crisis of 2008.

February 3, 2011

Drug Money

An article about payments from pharmaceutical companies to doctors in the Sacremento area quotes the Pew Health Group's Alan Coukell.

November 8, 2010

Drugs, Supplements Come to U.S. from China Largely Unregulated

 An article in The Kansas City Star about the lack of FDA oversight of foreign drugs and supplements, features Allan Coukell, director of Medical Safety for Pew Health Group.

September 1, 2010

FDA's Safety Role in Question After Egg Recall

A segment from Newshour about he recent salmonella-tainted egg recall features a comment from the Pew Health Group's Allan Coukell.

August 3, 2010

Consumer and Manufacturing Groups Back Bill to Protect U.S. Drug Supply after a Year of Record Recalls

The Pew Prescription Project announced support for a new bill that would give the U.S. Food and Drug Administration much-needed authorities to better protect pharmaceutical supply chains. The project also found only one in 10 Americans are confident in the quality of drugs made in India and China.

August 2, 2010

Voters Trust Drugs Made in USA, but Few Are

According to a poll by the Pew Charitable Trusts Prescription Project, voters are sure that drugs manufactured in the United States are free from contamination while drugs manufactered in India or China are not.

May 16, 2010

Under Pressure from Congress, Drugmakers are Starting to Disclose Payments Made to Doctors, Medical Professionals

Congress is starting to apply pressure to drug manufacturers to report payments made to medical professionals, an article in AZCentral.com says.

April 12, 2010

Data on Fees to Doctors Is Called Hard to Parse

The New York Times reports on databases that disclose payments from drug makers to doctors who act as consultants or speakers. The article quotes Allan Coukell, director of the Pew Prescription Project.

March 31, 2010

Pfizer Paid Doctors, Hospitals $35 Million in Last Half of 2009

A USA Today article on Pfizer's disclosure of its payments to doctors and other health professionals quotes Allan Coukell of the Pew Prescription Project.

March 31, 2010

Pfizer Gives Details on Payments to Doctors

The New York Times reports that Pfizer has disclosed details of payments to doctors and other medical professionals for consulting and speaking on its behalf. The article quotes Allan Coukell, director of the Pew Prescription Project.

March 26, 2010

Let the Sun Shine In: Payments to Docs from Companies to be Disclosed

The Wall Street Journal's Health Blog interviewed Allan Coukell, director of the Pew Prescription Project, about new legislation that will mandate disclosure of financial ties between doctors and drug companies.

March 23, 2010

Top U.S. Psychiatrist Calls for Ethics Cleanup

The Associated Press reports that the head of the National Institute of Mental Health has called for more transparency in psychiatry’s relationships with the drug industry. Allan Coukell, director of the Pew Prescription Project, is quoted.

March 22, 2010

Pew Prescription Project Statement on the Physician Payments Sunshine Act

Allan Coukell, director of the Pew Prescription Project, issued a statement commending Congress for including provisions from the Physician Payments Sunshine Act in health care reform legislation.

March 10, 2010

Statement on Congressional Hearing Regarding FDA Drug Safety Reforms

Allan Coukell, director of the Pew Prescription Project, issued a statement today, commenting on a drug safety hearing at the House Energy and Commerce subcommittee on Health.

 

February 28, 2010

Drugmakers Put Doctors on Marketing Payrolls

A Buffalo News article on fees that pharmaceutical companies pay to doctors quotes Allan Coukell of the Pew Prescription Project.

January 23, 2010

Glaxo, Merck Disclose How Much They're Paying U.S. Doctors

The Miami Herald reports that two more drug companies have released details on their payments to doctors. The piece quotes Allan Coukell of the Pew Prescription Project.

September 25, 2009

Mass. Doctors Get Big Money From Drug Companies

A Boston television station interviewed Allan Coukell of the Pew Prescription Project for a piece on payments from drug companies to doctors.

September 8, 2009

Free Drug Samples from a Doctor Sound Good, But They May Be Too New and Too Expensive

An article from The Plain Dealer about free samples given to physicians by pharmaceutical companies.

June 16, 2009

Medical Students, Pew Find Improvement in Medical School Pharmaceutical Conflict-of-Interest Policies, But Many Lag

Over one-fifth of U.S. medical schools improved their conflict-of-interest rules in the past year, yet dozens of others lag behind according to the 2009 American Medical Student Association (AMSA) PharmFree Scorecard.

January 22, 2009

The Prescription Project Applauds Legislation Requiring Disclosure of Physician-Industry Relationships

The statement of Robert Restuccia, Executive Director for The Prescription Project, regarding the revised Physician Payments Sunshine Act.

December 30, 2008

No Mug? Drug Makers Cut Out Goodies for Doctors

The New York Times reports that the pharmaceutical industry has agreed to a voluntary moratorium on branded goodies such as pens, soap dispensers and mugs. The piece quotes Allan Coukell, director of policy for the Prescription Project.

December 10, 2008

The Prescription Project Criticizes New PhRMA DTCA Guidelines

New guidelines fail to protect consumers from drug risks.

December 4, 2008

The Prescription Project Petitions FDA to Order Pharmaceutical and Medical Device Companies to Remove Illegal Internet Ads

The Prescription Project files a citizens petition with the Food and Drug Administration (FDA), asking the FDA to enforce its rules and require pharmaceutical and medical device companies  to withdraw illegal YouTube.com video advertisements for medical devices used in heart, hip and neck surgeries.

March 12, 2008

Testimony of Allan Coukell Before the Senate Special Committee on Aging

Academic detailing provides prescribers with unbiased information, encouraging the use of the safest, most effective and – other things being equal – least costly drugs.

More from the News Room

Related Experts

Jessica Donze Black

Director, Kids' Safe and Healthful Foods Project
The Pew Charitable Trusts
View: Profile

Laura Rogers

Director, Human Health and Industrial Farming
The Pew Charitable Trusts
View: Profile

Aaron Wernham

Director, Health Impact Project
The Pew Charitable Trusts
View: Profile

X
(All Fields are required)